Market Overview:
The global companion animal therapeutics market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of infectious diseases, dermatological diseases, orthopedic diseases, and behavioral disorders in companion animals. In addition, the increasing demand for therapeutic products for horses is also contributing to the growth of this market. The North American region dominates the global companion animal therapeutics market and is expected to continue its dominance during the forecast period. This region has a well-developed healthcare infrastructure and a high adoption rate of advanced technologies in veterinary care.
Product Definition:
Companion Animal Therapeutics is the use of animals to provide physical and emotional support for people with various health conditions or disabilities. The importance of Companion Animal Therapeutics is that it can help improve the quality of life for people who are struggling to cope with their condition or disability.
Infectious Diseases:
Infectious diseases are a major market for companion animal therapeutics. The global infectious disease market was valued at USD 44 billion in 2015 and is expected to grow at a CAGR of XX% during the forecast period. According to the Centers for Disease Control and Prevention (CDC), zoonotic diseases that are transmitted from animals to people accounted for more than 60% of all reported infections in U.S.
Dermatological Diseases:
Dermatological diseases are the group of disorders that affect skin, hair, and nails. These diseases can be acute or chronic in nature and can be categorized into two types: noninfectious (acute) and infectious (chronic). The most common dermatological conditions affecting companion animals include skin allergies/ sensitivities, demodicosis (a type of ringworm), atopic dermatitis (eczema), acne rosacea, etc.
Application Insights:
The dogs application segment led the market in 2017 and is anticipated to register a significant CAGR over the forecast period. This can be attributed to rising pet ownership, which has been increasing steadily since past few decades. Moreover, an increase in working class people owning pets like cats and dogs due to increased disposable income is expected to drive the demand for companion animal therapeutics over the forecast period.
The horses application segment was valued at USD 636.9 million in 2017 owing to its usage as a source of entertainment and recreation for centuries past among royals and aristocracy across various regions of world including Europe, Middle East, Asia Pacific etc.
Regional Analysis:
North America dominated the global companion animal therapeutics market in 2017. The presence of well-established veterinary healthcare facilities and high pet ownership are some of the major factors contributing to its growth. Moreover, increasing research funding for domestic animals is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income, improving standard of living, and growing population in countries such as India and China. Furthermore, government initiatives encouraging people with pets at home are also expected boost revenue generation in this region over the next eight years.
Growth Factors:
- Increasing demand for preventive healthcare services for animals
- Rising awareness about the benefits of animal therapy
- Growing number of veterinary clinics and hospitals
- Proliferation of pet-friendly policies and initiatives by governments and private organizations
- Technological advancements in Companion Animal Therapeutics
Scope Of The Report
Report Attributes
Report Details
Report Title
Companion Animal Therapeutics Market Research Report
By Type
Infectious Diseases, Dermatological Diseases, Orthopedic Diseases, Behavioral Disorders, Others
By Application
Dogs, Cats, Horses, Other
By Companies
Aratana Therapeutics, Elanco, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals, Eli Lilly and Company, Merck, Vetoquinol, Zoetis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Companion Animal Therapeutics Market Report Segments:
The global Companion Animal Therapeutics market is segmented on the basis of:
Types
Infectious Diseases, Dermatological Diseases, Orthopedic Diseases, Behavioral Disorders, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs, Cats, Horses, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aratana Therapeutics
- Elanco
- Boehringer Ingelheim GmbH
- Ceva Sante Animale
- Dechra Pharmaceuticals
- Eli Lilly and Company
- Merck
- Vetoquinol
- Zoetis
Highlights of The Companion Animal Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Infectious Diseases
- Dermatological Diseases
- Orthopedic Diseases
- Behavioral Disorders
- Others
- By Application:
- Dogs
- Cats
- Horses
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Companion Animal Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Companion Animal Therapeutics is a veterinary medical practice that specializes in the treatment of companion animals. They offer treatments such as vaccinations, deworming, dental care, and more.
Some of the major companies in the companion animal therapeutics market are Aratana Therapeutics, Elanco, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals, Eli Lilly and Company, Merck, Vetoquinol, Zoetis.
The companion animal therapeutics market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Companion Animal Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Companion Animal Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Companion Animal Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Companion Animal Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Companion Animal Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Companion Animal Therapeutics Market Size and Y-o-Y Growth
4.5.2 Companion Animal Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Companion Animal Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Companion Animal Therapeutics Market Size Forecast by Type
5.2.1 Infectious Diseases
5.2.2 Dermatological Diseases
5.2.3 Orthopedic Diseases
5.2.4 Behavioral Disorders
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Companion Animal Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Companion Animal Therapeutics Market Size Forecast by Applications
6.2.1 Dogs
6.2.2 Cats
6.2.3 Horses
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Companion Animal Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Companion Animal Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Companion Animal Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Companion Animal Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Companion Animal Therapeutics Market Size Forecast by Type
9.6.1 Infectious Diseases
9.6.2 Dermatological Diseases
9.6.3 Orthopedic Diseases
9.6.4 Behavioral Disorders
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Companion Animal Therapeutics Market Size Forecast by Applications
9.10.1 Dogs
9.10.2 Cats
9.10.3 Horses
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Companion Animal Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Companion Animal Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Companion Animal Therapeutics Market Size Forecast by Type
10.6.1 Infectious Diseases
10.6.2 Dermatological Diseases
10.6.3 Orthopedic Diseases
10.6.4 Behavioral Disorders
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Companion Animal Therapeutics Market Size Forecast by Applications
10.10.1 Dogs
10.10.2 Cats
10.10.3 Horses
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Companion Animal Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Companion Animal Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Companion Animal Therapeutics Market Size Forecast by Type
11.6.1 Infectious Diseases
11.6.2 Dermatological Diseases
11.6.3 Orthopedic Diseases
11.6.4 Behavioral Disorders
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Companion Animal Therapeutics Market Size Forecast by Applications
11.10.1 Dogs
11.10.2 Cats
11.10.3 Horses
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Companion Animal Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Companion Animal Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Companion Animal Therapeutics Market Size Forecast by Type
12.6.1 Infectious Diseases
12.6.2 Dermatological Diseases
12.6.3 Orthopedic Diseases
12.6.4 Behavioral Disorders
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Companion Animal Therapeutics Market Size Forecast by Applications
12.10.1 Dogs
12.10.2 Cats
12.10.3 Horses
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Companion Animal Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Companion Animal Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Companion Animal Therapeutics Market Size Forecast by Type
13.6.1 Infectious Diseases
13.6.2 Dermatological Diseases
13.6.3 Orthopedic Diseases
13.6.4 Behavioral Disorders
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Companion Animal Therapeutics Market Size Forecast by Applications
13.10.1 Dogs
13.10.2 Cats
13.10.3 Horses
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Companion Animal Therapeutics Market: Competitive Dashboard
14.2 Global Companion Animal Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Aratana Therapeutics
14.3.2 Elanco
14.3.3 Boehringer Ingelheim GmbH
14.3.4 Ceva Sante Animale
14.3.5 Dechra Pharmaceuticals
14.3.6 Eli Lilly and Company
14.3.7 Merck
14.3.8 Vetoquinol
14.3.9 Zoetis
